Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 65Neoplasms 56Prostatic Neoplasms 44Lung Neoplasms 35Colorectal Neoplasms 35Carcinoma, Non-Small-Cell Lung 24Pancreatic Neoplasms 21Hematologic Neoplasms 19Head and Neck Neoplasms 16Neoplasm Metastasis 15Urinary Bladder Neoplasms 12Ovarian Neoplasms 11Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Motor Activity 10Triple Negative Breast Neoplasms 9Multiple Myeloma 9Colonic Neoplasms 9Melanoma 8Glioma 8Anxiety Disorders 8Uterine Cervical Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 7Glioblastoma 7Gastrointestinal Neoplasms 7Esophageal Neoplasms 7Anatomic Stage I Breast Cancer AJCC v8 7Smoking Cessation 6Sarcoma 6Rectal Neoplasms 6

Interventions

Metformin 7Surveys and Questionnaires 3Nutrition Assessment 3Exercise 3Tirzepatide 2Therapeutics 2Tablets 2Standard of Care 2Specimen Handling 2Resistance Training 2Methods 2Interviews as Topic 2Glucose Tolerance Test 2Educational Status 2Biopsy 2tocilizumab 1tislelizumab 1pembrolizumab 1epalrestat 1donafenib 1amlodipine, atorvastatin drug combination 1Verapamil 1Urine Specimen Collection 1Testosterone 1Secretin 1Second Harmonic Generation Microscopy 1Risk Assessment 1Remote Consultation 1Preventive Health Services 1Practice Guidelines as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus × Standard of Care × Clear all
NCT05377320 2025-10-14

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Medical College of Wisconsin

Not yet recruiting
60 enrolled

Coronary Artery Disease, Diabetes Mellitus, Heart Failure, Hypertension, Ischemia, Cardiomyopathies, Neoplasms, Peripheral Arterial Disease, Cardiotoxicity

NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Emory University

Phase 3 Withdrawn
Genitourinary

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡